Clinical trial
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the…
NCT00215345 · Department of Veterans Affairs, New Jersey, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00215345 |
|---|---|
| Title | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer |
| Official title | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer |
| Lead sponsor | Department of Veterans Affairs, New Jersey, U.S. Fed |
| Collaborators | Pfizer Industry Sanofi |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Taxotere, Celecoxib |
| Enrollment | 66 |
| Start date | Aug 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: